Cargando…
A Prospective Cohort Study on the Safety of Infant Pentavalent (DTwP-HBV-Hib) and Oral Polio Vaccines in Two South Indian Districts
BACKGROUND: Safety of pentavalent (DTwP-HBV-Hib) vaccine has been a public concern in India and other countries. This study attempted to document the association of serious adverse events following immunization (AEFI, including hospitalizations and deaths of all causes) with the 3 doses of pentavale...
Autores principales: | Arora, Narendra Kumar, Das, Manoja Kumar, Poluru, Ramesh, Kashyap, Neeraj Kumar, Mathew, Thomas, Mathai, John, Aggarwal, Mahesh Kumar, Haldar, Pradeep, Verstraeten, Thomas, Zuber, Patrick L. F. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Williams & Wilkins
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7170438/ https://www.ncbi.nlm.nih.gov/pubmed/32301918 http://dx.doi.org/10.1097/INF.0000000000002594 |
Ejemplares similares
-
Safety and immunogenicity of a new formulation of a pentavalent DTwP-HepB-Hib vaccine in healthy Indian infants–A randomized study
por: Aloysia D’Cor, Naveena, et al.
Publicado: (2023) -
Safety and immunogenicity of a hexavalent DTwP-IPV-HB-PRP∼T vaccine versus separate DTwP-HB-PRP∼T and IPV vaccines in healthy infants in India
por: Mangarule, S., et al.
Publicado: (2022) -
Antibody persistence following administration of a hexavalent DTwP-IPV-HB-PRP∼T vaccine versus separate DTwP-HB-PRP∼T and IPV vaccines at 12–24 months of age and safety and immunogenicity of a booster dose of DTwP-IPV-HB-PRP∼T in healthy infants in India
por: Mangarule, S, et al.
Publicado: (2022) -
Immunological Links to Nonspecific Effects of DTwP and BCG Vaccines on Infant Mortality
por: Claesson, Mogens Helweg
Publicado: (2011) -
DTwP-HB-Hib: antibody persistence after a primary series, immune response and safety after a booster dose in children 18–24 months old
por: Gunardi, Hartono, et al.
Publicado: (2018)